Answers are grounded in this paper and cite their sources.
Cancer stem cells (CSCs)/cancer-initiating cells (CICs) are characterized as a small population of cancer cells that have high tumor-initiating ability. CSCs/CICs are resistant to several cancer therapies, and eradication of CSCs/CICs is essential to cure cancer. How can we eradicate CSCs/CICs? Cytotoxic T lymphocytes (CTLs) might be a promising answer.
No takes yet. Share an insight, caveat, or question.
Hirohashi et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: